Certificate of Analysis for Peptides UK: The Verification Checklist

What Does a Peptide Certificate of Analysis Actually Certify?

A Certificate of Analysis (COA) is a laboratory document that reports what a specific manufactured batch was found to contain when it was tested, not what the label says it should contain. For a research peptide, a COA worth reading states three things in combination: the purity of the main peptide by a stated analytical method, the identity of that peptide confirmed by a separate method, and the batch or lot number the results apply to. Strip any one of those three out and the remaining two tell you very little: a purity figure with no identity confirmation could be 98% pure contamination, and an identity match with no purity figure tells you nothing about how much of the vial is actually the peptide in question.

Why Does Purity Need Independent Verification in the First Place?

Because synthetic peptide chemistry does not reliably produce a clean product on the first pass. Solid-phase peptide synthesis builds a chain one amino acid at a time, and at each coupling step a small fraction of reactions fail, truncate, or form side products. The crude product of that process therefore contains the target sequence alongside deletion sequences, incomplete couplings and other by-products (the Fmoc method is reviewed in the Journal of Peptide Science: Behrendt, White & Offer, J Pept Sci, 2016, PMID 26785684). Purification by preparative HPLC is what raises purity toward 98% or higher, and the only way to know whether a given batch actually reached that threshold is to run it through analytical HPLC again and report the result. A COA is, in effect, the paper record of that second check. Without it, a buyer has no way to distinguish a well-purified batch from unpurified crude material repackaged with a confident label.

What Should the Purity Result on the COA State?

It should state a specific percentage, the analytical method used to reach it, and ideally the column and detection wavelength, so the figure can be assessed rather than taken on trust. Reverse-phase HPLC is the standard method for peptide purity determination, and a result is reported as the area of the main peak relative to total peak area across the chromatogram. A COA that states only "purity: 99%" with no method named, no chromatogram attached, and no reference standard described is reporting a number with no way to check it. A COA that includes the chromatogram image, the column type, the mobile phase, and the integration method gives a reader something they can actually evaluate against the raw data.

How Is Identity Confirmed, Separately From Purity?

Identity is normally confirmed by mass spectrometry, which measures the molecular weight of the material and compares it against the expected molecular weight of the target sequence. A purity figure describes how much of the sample is one dominant component; it does not confirm what that component is. A batch could register a clean, narrow 98% peak on HPLC and still not be the peptide the label claims, if the dominant component is a different molecule of similar retention time. Mass spectrometry closes that gap by matching the measured mass to the calculated mass of the correct sequence, usually reported with a tolerance in daltons. A credible COA reports both figures, from two different instruments, because each one tests something the other cannot.

What Does the Batch or Lot Number Actually Prove?

It ties the specific test results on the document to one specific manufacturing run, and nothing else. Peptide synthesis is a batch process: each run can vary slightly in yield and purity depending on reagent quality, reaction conditions, and purification efficiency on the day. A COA is only meaningful for the exact lot number it references. A supplier that reuses one old COA across multiple batches, or that cannot produce a COA matching the lot number printed on the vial in hand, is providing evidence about a different, earlier batch that may or may not resemble the product actually being sold.

Which Laboratory Credentials Make a COA Trustworthy?

Independence and accreditation. A COA produced by the manufacturer's own in-house quality team is a self-report; a COA produced by an unrelated third-party laboratory is an independent check, and that distinction matters considerably more than the number printed on the page. The relevant quality standard for a chemical testing laboratory is ISO/IEC 17025, and in the UK the national accreditation body is UKAS, the United Kingdom Accreditation Service, which maintains a public register of accredited laboratories searchable by name and scope. A COA naming an accredited lab and quoting a checkable accreditation number allows a reader to confirm the lab exists, is accredited for the relevant test, and is not simply a name invented for the document.

What Are the Most Common Red Flags in a UK Peptide COA?

The most frequent problem is a document that reports a number with none of the supporting detail described above: no method, no instrument, no chromatogram, no accreditation reference, and often a lot number that does not appear anywhere on the product packaging. A second common pattern is a COA dated well before the batch it supposedly covers, or reused verbatim across multiple product listings with only the peptide name changed. A third is a "laboratory" name that does not appear on the UKAS register, or appears with an accreditation scope that does not actually cover the test being claimed. None of these are difficult to check; they simply require reading the document instead of the headline percentage.

Does an Independent COA Change the Regulatory Status of a Peptide in the UK?

No. The two questions are often conflated, so it is worth being plain: a COA answers a chemistry question: what is in this vial, and how pure is it. It does not answer a legal question: is this substance authorised for human use in the UK. Under the Human Medicines Regulations 2012, a medicinal product requires a marketing authorisation from the MHRA, the Medicines and Healthcare products Regulatory Agency, before it can lawfully be supplied for human therapeutic use. Research peptides sold for laboratory use are generally outside that licensed framework, a status that is unaffected by how clean or well-documented the batch is. A COA and an MHRA marketing authorisation are separate documents, and a seller presenting one as evidence of the other is not describing the regulatory position accurately. Current guidance and the public register of licensed medicines are maintained by the MHRA at gov.uk/MHRA.

How Should a Reader Cross-Check a COA Before Relying on It?

Three checks cover most of what matters. First, confirm the lot number on the COA matches the lot number on the physical packaging; a mismatch invalidates the document for that item. Second, look up the named laboratory on the UKAS accreditation register and confirm its accreditation scope actually includes the test method cited. Third, check that both a purity figure (HPLC) and an identity figure (mass spectrometry) are present with methods stated, rather than one number standing in for both. A document that passes all three is evidence about the batch's chemistry. It is still not evidence about the batch's UK legal status, which is a separate and unconnected question addressed by MHRA licensing, not by laboratory testing.

Certificate of Analysis for UK Peptides: The Short Answer

Read for purity by HPLC with the method shown, identity by mass spectrometry, a matching batch number, and an accredited independent laboratory you can verify on the UKAS register. Treat the document as a chemistry record of one specific batch, not as a statement about UK regulatory status, since research peptides generally sit outside MHRA licensing for human use regardless of how the COA reads. A document missing any of the four elements above does not verify the batch.